4//SEC Filing
PARMAR KUSH 4
Accession 0001415889-25-018824
CIK 0001689375other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 8:33 PM ET
Size
13.5 KB
Accession
0001415889-25-018824
Insider Transaction Report
Form 4
PARMAR KUSH
Director10% Owner
Transactions
- Sale
Common Stock
2025-07-01$7.12/sh−18,578$132,324→ 3,183,131 total(indirect: By 5AM Ventures V, L.P.) - Sale
Common Stock
2025-07-01$7.12/sh−6,422$45,741→ 1,100,248 total(indirect: By 5AM Opportunities I, L.P.) - Sale
Common Stock
2025-06-27$6.91/sh−55,735$385,129→ 3,220,287 total(indirect: By 5AM Ventures V, L.P.) - Sale
Common Stock
2025-06-27$6.91/sh−19,265$133,121→ 1,113,092 total(indirect: By 5AM Opportunities I, L.P.) - Sale
Common Stock
2025-06-30$6.81/sh−6,422$43,751→ 1,106,670 total(indirect: By 5AM Opportunities I, L.P.) - Sale
Common Stock
2025-06-30$6.81/sh−18,578$126,566→ 3,201,709 total(indirect: By 5AM Ventures V, L.P.)
Footnotes (2)
- [F1]Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Kush M. Parmar, M.D., Ph.D. is a managing member of 5AM Partners and may be deemed to share voting and investment power over the shares held by 5AM V. Dr. Parmar disclaims beneficial ownership of the shares held by 5AM V except to the extent of his pecuniary interest therein.
- [F2]Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Kush M. Parmar, M.D., Ph.D. is a managing member of Opportunities GP and may be deemed to share voting and investment power over the shares held by Opportunities. Dr. Parmar disclaims beneficial ownership of the shares held by Opportunities except to the extent of his pecuniary interest therein.
Documents
Issuer
Entrada Therapeutics, Inc.
CIK 0001689375
Entity typeother
Related Parties
1- filerCIK 0001664281
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 8:33 PM ET
- Size
- 13.5 KB